Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1841 |
UNC0379
|
Histone Methyltransferase | Chromatin/Epigenetic |
UNC0379 是一种选择性的、底物竞争性的赖氨酸甲基转移酶 SETD8 抑制剂,IC50值为 7.3 μM,也选择性抑制其他 15 种甲基转移酶。 | |||
T17203 |
UNC0224
|
Histone Methyltransferase | Chromatin/Epigenetic |
UNC0224 是 G9a 的特异性抑制剂,Ki 为 2.6 nM,IC50 为 15 nM。 UNC0224 还有效抑制 GLP,IC50 值为 20-58 nM。 | |||
T4583 |
PFI-2 hydrochloride
(R)-PFI-2 hydrochloride,PFI-2 HCl |
Histone Methyltransferase | Chromatin/Epigenetic |
PFI-2 hydrochloride ((R)-PFI-2 hydrochloride) 是一种有效的、高度选择性的、具有细胞活性的 SETD7 甲基转移酶抑制剂,IC50值为2nM,活性是 (S)-PFI-2 的 500 倍。 | |||
T1987 |
PFI-2
PFI2,PFI 2,(R)-PFI-2 |
Histone Methyltransferase | Chromatin/Epigenetic |
PFI-2 是一种有效、特异性和细胞活性的赖氨酸甲基转移酶 SETD7 抑制剂,Ki 和 IC50值分别为 0.33 和 2 nM。 | |||
T7305 |
JQEZ5
|
Histone Methyltransferase | Chromatin/Epigenetic |
JQEZ5 是一种选择性EZH2赖氨酸甲基转移酶抑制剂,具有抗肿瘤作用。它以 SAM 竞争性方式抑制PRC2的酶功能,IC50为 80 nM。 | |||
T14841 |
BVT948
|
Phosphatase; P450; Histone Methyltransferase | Chromatin/Epigenetic; Metabolism |
BVT948 是一种蛋白酪氨酸磷酸酶抑制剂,还可以抑制赖氨酸甲基转移酶 SETD8 (KMT5A) 和几种细胞色素 P450 (P450) 同工型。 | |||
T6879 |
LLY-507
LLY507,LLY 507 |
Histone Methyltransferase | Chromatin/Epigenetic |
LLY-507 是一种有效的、细胞活性的、特异性的蛋白质赖氨酸甲基转移酶 SMYD2 抑制剂。它是一种化学探针,用于解析 SMYD2 在癌症和其他生物过程中的功能。它有抑制 SMYD2 甲基化 p53 肽的能力,IC50小于 15 nM。 | |||
TQ0232 |
UNC0646
UNC 0646 |
Histone Methyltransferase | Chromatin/Epigenetic |
UNC0646 是一种有效的、选择性的同源蛋白赖氨酸甲基转移酶 G9a 和 GLP 抑制剂,IC50分别为 6 和 15 nM,对 G9a/GLP 的选择性比 SETD7、SUV39H2、SETD8 和 PRMT3 高。它降低 MDA-MB-231 细胞中H3K9me2的水平,IC50为 26 nM。 | |||
T25471 |
GSK-A
GSK A |
||
GSK-A is a Histone Lysine Methyltransferase EZH2 inhibitor. | |||
T10553 |
BIX-01338 hydrate
|
Others | Others |
BIX-01338 hydrate is an inhibitor of histone lysine methyltransferase. | |||
T28111 |
MS012
MS-012,MS 012 |
||
MS012 is a Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine Methyltransferase (Kd = 46 ± 15 nM). | |||
T36799 | UNC 2399 | ||
Biotinylated UNC 1999 (Cat.No. 4904, IC50 = 17 nM). Enriches lysine methyltransferase EZH2 from HEK293T cells. Negative control also avilable. 0 | |||
T40993 |
Histone H3 (1-21)
Histone H3 (1-21) |
||
Histone H3 (1-21) is a truncated form of the Histone H3 protein consisting of amino acids 1 to 21. It serves as a common substrate for methyltransferase assays targeting Histone 3 at lysine 4 and lysine 9, as well as for acetyltransferase assays targeting Histone 3 at lysine 9 and lysine 14. | |||
T69624 |
TC-5115
|
||
TC-5115 is a potent inhibitor of MLL methyltransferase with IC50 value of 16 nM. TC-5115 may lead to the development of a new therapy for the treatment of human MLL leukemia. The mixed-lineage leukemia (MLL) protein, also known as MLL1, is a lysine methyltransferase specifically responsible for methylation of histone 3 lysine 4. MLL has been pursued as an attractive therapeutic target for the treatment of acute leukemia carrying the MLL fusion gene or MLL leukemia. | |||
T11185 |
EML741
|
Histone Methyltransferase | Chromatin/Epigenetic |
EML741 also inhibits DNMT1 (IC50, 3.1 μM), with no effect on DNMT3a or DNMT3b. EML741 exhibits low cell toxicity, and is membrane permeable and blood-brain barrier penetrated. EML741 is a histone lysine methyltransferase G9a/GLP inhibitor, with an IC50 of 23 nM, Kd of 1.13 μM for G9a. | |||
T81175 | SETD7-IN-1 | Histone Methyltransferase | Chromatin/Epigenetic |
SETD7-IN-1 (compound 7) 为 PFI-2 类似物,兼具组蛋白赖氨酸甲基转移酶SETD7的底物与抑制剂功能,展现出 0.96±0.10 µM 的 IC50 值。 | |||
T22250 |
5WKS
ZINC97756584 |
Others | Others |
5WKS 也称为ZINC97756584,是一种生物化学物质。它是G9a 蛋白抑制剂。G9A/EHMT2是一种核组蛋白赖氨酸甲基转移酶,催化H3K9me2,这是一种通常与转录基因沉默相关的可逆修饰。5WKS 可用于自身免疫性疾病或肿瘤的研究。 | |||
T63705 |
UNC0379 TFA
|
||
UNC0379 TFA 是选择性的、底物竞争性的赖氨酸甲基转移酶 SETD8(KMT5A) 抑制剂 (IC50: 7.3 μM),对其他 15 种甲基转移酶表现出良好的选择性。 | |||
T28114 |
MS2177
MS 2177,MS-2177 |
||
MS2177 is a potent and selective inhibitor of SETD8, the only methyltransferase known to catalyze monomethylation of histone H4 lysine 20 (H4K20). MS2177 has an in vitro IC50 of 1.9 μM (σ = 1.05 μM, n = 4) in ascintillation proximity assay. Binding of MS2 | |||
T26744 |
BAY-598 R-isomer
BAY598 R-isomer,BAY 598 R-isomer |
||
BAY-598 R-异构体是BAY589的R-异构体,它可用作参考化合物。它是是赖氨酸N-甲基转移酶(SMYD2)的抑制剂,对SMYD2比蛋白酶激活的受体1(PAR1)具有选择性。 | |||
T36802 |
Bisubstrate Inhibitor 78
|
||
Bisubstrate inhibitor 78 is an inhibitor of nicotinamide N-methyltransferase (NNMT; IC50= 1.41 μM).1It binds the NNMT active site in the binding pockets for the NNMT substrates S-adenosyl-L-methionine (SAM) and nicotinamide . Bisubstrate inhibitor 78 is selective for NNMT over histone-lysine N-methytransferase NSD2 and protein arginine methyltransferase 1 (PRMT1; IC50s = >50 μM for both). It reduces levels of 1-methylnicotinamide in, and inhibits proliferation of, HSC-2 oral cancer cells when us... | |||
T36576 |
Histone H3 (21-44)-GK-biotin (trifluoroacetate salt)
Histone H3 (21-44)-GK-biotin (trifluoroacetate salt) |
||
Histone H3 (21-44)-GK-biotin is a peptide fragment of histone H3 that corresponds to amino acid residues 22-45 of the human histone H3.1 and 3.2 sequences and is biotinylated via a C-terminal GK linker. Histone H3 (21-44) contains a lysine residue at position 23 that is subject to acetylation, an arginine at position 26 subject to methylation, and a serine at position 28 subject to phosphorylation, as well as lysine residues at positions 27 and 36 that are subject to methylation and acetylation.... | |||
T35567 |
BIX01294 (hydrochloride hydrate)
|
||
The methylation of lysine residues on histones plays a central role in determining euchromatin structure and gene expression. The histone methyltransferase (HMTase) G9a can mono- or dimethylate lysine 9 on histone 3 (H3), contributing to early embryogenesis, genomic imprinting, and lymphocyte development. BIX01294 (hydrochloride hydrate) is a selective inhibitor of G9a HMTase (IC50 = 1.7 μM). It less effectively inhibits the HMTase G9a-like protein (GLP; IC50 = 38 μM) and has no effect on other ... | |||
T79776 |
ZZM-1220
|
Histone Methyltransferase | Chromatin/Epigenetic |
ZZM-1220是一种针对组蛋白赖氨酸甲基转移酶G9a/GLP的共价抑制剂,IC50值分别为458 nM和924 nM。该化合物能有效抑制H3K9me2在细胞中的作用,从而显著促进三阴性乳腺癌(TNBC)细胞的凋亡(apoptosis),同时在G2/M期阻断细胞周期的进程。 | |||
T73225 |
OTS193320
|
||
OTS193320 是一种咪唑并 [1,2-a] 吡啶化合物,一种 SUV39H2甲基转移酶活性抑制剂。OTS193320 降低乳腺癌细胞中的全局组蛋白 H3 赖氨酸 9 三甲基化水平并引发凋亡细胞死亡。与单一药剂 OTS193320 或 DOX 相比,OTS193320 与 Doxorubicin(DOX) 的组合可以导致 γ-H2AX 水平以及癌细胞活力的降低。 | |||
T83755 |
ssK36 TFA
|
||
ssK36是一种针对组蛋白甲基转移酶SET结构域含蛋白2 (SETD2) 的肽类超级底物,其对应于组蛋白H3赖氨酸36 (H3K36) 的第29至43个氨基酸,且在第31、32、36、37和39位氨基酸上发生了置换。在无细胞检测中,ssK36的甲基化程度比H3K36 (29-43) 高70倍,速度快290倍。 | |||
T83867 |
UNC8153 TFA
|
||
UNC8153 是一种 NSD2(组蛋白-赖氨酸 N-甲基转移酶)的降解剂,其通过诱导NSD2的降解,具有350 nM的50%降解常数(DC50)值,并且在20 µM浓度下对NSD2具有选择性,而不选择NSD1和NSD3。在MM.1S多发性骨髓瘤细胞中,UNC8153 (10 µM) 能够诱导NSD2降解并减少组蛋白H3赖氨酸36位二甲基化(H3K36me2),这一效应可以被泛素激活酶抑制剂MLN4924所抑制。它减少了表达带有在1099位上谷氨酸到赖氨酸激活突变的NSD2(NSD2E1099K)的MM.1S细胞的增殖,但在20 µM浓度下,对表达野生型NSD2的MDA-MB-231、U2OS或HEK293细胞无效。UNC8153 (20 µM) 降低了在迁移实验中MM.1S细胞的附着能力。 |